Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 17, 2025
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-09-15$24.19/sh−189$4,572→ 53,468 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on September 12, 2025.